^{_{Welcome to the TraderTV Live Morning Research Note. Here's what's making major moves in the market today.}}

0830 - Fed Chair Powell speaks (pre-recorded)
0830 - Initial jobless claims (tentative): Prior 218k
0835 - Fed’s Bowman speaks
0845 - Treasury Sec. Bessent speaks
1000 - Wholesale inventories m/m (tentative): Expected -0.2%; Prior -0.2%
1245 - Fed’s Kashkari speaks
1300 - Fed’s Kashkari and Fed’s Barr speak

Advanced Micro Devices Inc (AMD)

+1.19%

Poised for a fourth straight green session after gaining 43% over the last three days, the stock’s best three-day run in nine years. The rally to new all-time highs was driven by the company’s partnership with OpenAI, announced on Monday. The deal gives OpenAI the potential to own a 10% stake in AMD.

NVIDIA Corp (NVDA)

+1.41%

Bloomberg reported that the US has approved several billion dollars’ worth of Nvidia chip exports to the United Arab Emirates under a bilateral AI agreement reached in May. The deal, which includes reciprocal UAE investments in the US, aims to accelerate the UAE’s development of AI data centers and strengthen the nations’ AI partnership. Separately, Cantor Fitzgerald raised its price target on the stock from $240 to a Street high of $300 after hosting the company’s management for a series of investor meetings earlier this week.

Delta Air Lines Inc (DAL)

+4.60%

Trading sharply higher premarket after its Q3 2025 earnings report, with adjusted earnings of $1.71 per share and sales of $16.673 billion beating estimates of $1.52 and $15.041 billion, respectively. The company guided adjusted earnings between $1.60 and $1.90 per share for Q4, compared to estimates of $1.64. Delta also narrowed its adjusted EPS guidance for the fiscal year from $5.25-$6.25 to $6.00, beating estimates of $5.76.

Tesla Inc (TSLA)

-1.12%

The US National Highway Traffic Safety Administration has launched an investigation into 2.88 million Tesla vehicles with Full Self-Driving after reports of crashes and traffic law violations. The agency cited incidents where Teslas allegedly ran red lights or changed lanes improperly. This investigation marks the the first step toward a possible recall if safety risks are confirmed.

Ferrari NV (RACE)

-14.03%

Gapping down after Ferrari unveiled its 2030 roadmap at Capital Markets Day. The company confirmed plans to launch four new models per year from 2026–2030 and teased the debut of its first fully electric “Ferrari elettrica” in late 2026, with its lineup set to be 40% ICE, 40% hybrid, and 20% electric by decade’s end. Ferrari emphasized global retail and training expansions and major emission cuts going forward, expecting adjusted EBITDA of at least 3.6 billion euros for FY30. The company also announced that their dividend payout will be increased to 40% of net, starting from the current year.

Tilray Brands (TLRY)

+14.53%

Gapping up after its Q1 2026 earnings report. The company reported earnings of $0.00 per share, better than the estimated loss of $0.02 per share, with sales of $209.501 million beating estimates of $205 million and marking a 5% year-over-year improvement. Adjusted EBITDA grew by 9% year-over-year, though gross margin and gross profit both contracted. Tilray maintained its previously-stated adjusted EBITDA guidance of $62 million to $72 million for fiscal 2026.

PepsiCo Inc (PEP)

+0.84%

Trading marginally higher following its Q3 2025 earnings report. Adjusted earnings of $2.29 per share beat estimates of $2.26, and sales of $23.937 billion exceeded expectations of $23.827 billion. The company reiterated that it expects organic growth in the low single digits for fiscal 2025, with core EPS expected to be flat on a year-over-year basis. Pepsi also announced the appointment of Steve Schmitt as CFO and executive vice president amid the retirement of Jamie Caulfield.

Novo Nordisk A/S (NVO)

-1.36%

The company’s US-listed shares are trading lower premarket after announcing plans to acquire Akero Therapeutics (AKRO). Novo Nordisk is set to acquire Akero, a US-based biotech company, for $54 per share. Akero closed Wednesday’s session at $46.49 and is gapping up following the acquisition announcement.

Taiwan Semiconductor Manufacturing Co Ltd (TSM)

-0.47%

Trading marginally lower premarket after reporting sales for September 2025. Revenue for the month was reported at 330.98 billion New Taiwanese dollars, up 31.4% from September 2024 but down 1.4% compared to August 2025. Taiwan Semiconductor’s cumulative revenue from January to September 2025 reached 2.76 trillion New Taiwanese dollars, representing a 36.4% gain compared to the same period in 2024.

Microsoft Corp (MSFT)

-0.06%

The Wall Street Journal reported that the company is developing proprietary AI models to lessen its dependence on OpenAI and enhance its Copilot ecosystem. Led by Mustafa Suleyman, the company’s AI division is expanding its team and plans to train in-house models that could eventually replace OpenAI-powered workloads.

Meta Platforms, Alphabet, and Snap Inc

-0.15%

New York City has filed a 327-page federal lawsuit against a series of social media companies, including these three companies and Bytedance. The suit alleges that these companies intentionally designed their platforms to addict children and fuel a youth mental health crisis. Separately, the CEO of Ray-Ban maker EssilorLuxottica told Bloomberg about plans to scale Ray-Ban Meta production over the next year, viewing these glasses as a possible replacement for smartphones. Alphabet is also on watch after Google Cloud announced Gemini Enterprise, an AI platform to compete with products from OpenAI and Microsoft.

META, GOOGL, SNAP

Helen of Troy Ltd (HELE)

-14.89%

Gapping down following its Q2 2026 earnings report. Adjusted earnings of $0.59 per share and sales of $431.781 million beat estimates of $0.53 and $418.806 million, respectively. The company’s adjusted EPS guide of $1.55 to $1.80 per share for Q3 missed estimates of $1.98, though its GAAP EPS guide for the same quarter exceeded expectations. Helen of Troy guided steeper-than-expected GAAP losses per share for the fiscal year; its adjusted EPS guide for the same period similarly missed estimates, and its sales outlook was in-line.

Bluejay Diagnostics Inc (BJDX)

+122.99%

Gapping up after amending its agreements with Japan-based SanyoSeiko to expand the latter’s role in commercializing Bluejay’s Symphony rapid testing platform for critical care biomarkers like IL-6. Under the new terms, SanyoSeiko will provide full-scale manufacturing, supply chain, regulatory, and quality management support for the Symphony analyzers and cartridges. The company has a market capitalization of $2.79 million and a float of 1.49 million shares, approximately 6.3% of which are sold short.